NASDAQ:RCEL Avita Medical (RCEL) Stock Price, News & Analysis $5.47 -0.05 (-0.91%) Closing price 04:00 PM EasternExtended Trading$5.42 -0.05 (-0.91%) As of 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Avita Medical Stock (NASDAQ:RCEL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Avita Medical alerts:Sign Up Key Stats Today's Range$5.41▼$5.5750-Day Range$4.17▼$6.7652-Week Range$3.60▼$14.16Volume144,089 shsAverage Volume1.31 million shsMarket Capitalization$145.61 millionP/E RatioN/ADividend YieldN/APrice Target$11.60Consensus RatingHold Company Overview Avita Medical, Inc. (NASDAQ: RCEL) is a regenerative medicine company focused on the development and commercialization of cell‐based therapies for acute and chronic wounds. Its flagship technology, the ReCell® Autologous Cell Harvesting Device, enables clinicians to create a suspension of a patient’s own skin cells at the point of care. The system is designed to accelerate wound healing, minimize donor‐site requirements and reduce scarring for patients suffering from burns, traumatic wounds and a variety of surgical and reconstructive procedures. Founded in 2009 and headquartered in Carlsbad, California, Avita Medical has secured regulatory clearances in key markets, including CE mark approval in the European Union and 510(k) clearance from the U.S. Food and Drug Administration for acute thermal burn wounds. The company has since expanded its clinical indications and market access efforts into regions such as Australia, China and other parts of Asia. Avita collaborates with leading burn centers, academic institutions and investigator‐initiated trials to explore additional applications—ranging from chronic diabetic ulcers to vitiligo and hair restoration. Under the leadership of President and Chief Executive Officer Michael Perry, Avita Medical has emphasized the integration of its proprietary cell‐harvesting technology into standard burn and wound care protocols. The company maintains a global commercial infrastructure to support physician training, clinical research, and post‐market surveillance. Its strategic priorities include broadening clinical adoption of ReCell, pursuing new regulatory approvals and fostering partnerships to extend its regenerative platform into adjacent markets.AI Generated. May Contain Errors. Read More Avita Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScoreRCEL MarketRank™: Avita Medical scored higher than 39% of companies evaluated by MarketBeat, and ranked 708th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingHold Consensus RatingAvita Medical has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 3 buy ratings, 1 hold rating, and 2 sell ratings.Upside PotentialAvita Medical has a consensus price target of $11.60, representing about 112.1% upside from its current price of $5.47.Amount of Analyst CoverageAvita Medical has only been the subject of 4 research reports in the past 90 days.Read more about Avita Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Avita Medical are expected to grow in the coming year, from ($0.95) to ($0.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avita Medical is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avita Medical is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvita Medical has a P/B Ratio of 32.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Avita Medical's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted18.47% of the float of Avita Medical has been sold short.Short Interest Ratio / Days to CoverAvita Medical has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in Avita Medical has recently decreased by 1.52%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAvita Medical does not currently pay a dividend.Dividend GrowthAvita Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted18.47% of the float of Avita Medical has been sold short.Short Interest Ratio / Days to CoverAvita Medical has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in Avita Medical has recently decreased by 1.52%, indicating that investor sentiment is improving. News and Social Media0.0 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 5 news articles for Avita Medical this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for RCEL on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Avita Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $113,660.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.80% of the stock of Avita Medical is held by insiders.Percentage Held by InstitutionsOnly 27.66% of the stock of Avita Medical is held by institutions.Read more about Avita Medical's insider trading history. Receive RCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avita Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RCEL Stock News HeadlinesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCELOctober 3, 2025 | prnewswire.comAVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into AVITA Medical, Inc. and Encourages Investors to Contact the FirmOctober 3, 2025 | globenewswire.comURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.October 7 at 2:00 AM | StockEarnings (Ad)Avita Medical to be eligible for NTAP reimbursement from CMS for RECELLOctober 1, 2025 | msn.comCMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute WoundsOctober 1, 2025 | globenewswire.comBrokerages Set Avita Medical Inc. (NASDAQ:RCEL) PT at $11.60October 1, 2025 | americanbankingnews.comSecurities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzSeptember 29, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical, Inc. - RCELSeptember 28, 2025 | prnewswire.comSee More Headlines RCEL Stock Analysis - Frequently Asked Questions How have RCEL shares performed this year? Avita Medical's stock was trading at $12.80 at the start of the year. Since then, RCEL stock has decreased by 57.3% and is now trading at $5.47. How were Avita Medical's earnings last quarter? Avita Medical Inc. (NASDAQ:RCEL) posted its earnings results on Thursday, August, 7th. The company reported ($0.38) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by $0.12. The firm had revenue of $18.42 million for the quarter, compared to analysts' expectations of $34.27 million. Avita Medical had a negative trailing twelve-month return on equity of 632.62% and a negative net margin of 68.87%. Read the conference call transcript. How do I buy shares of Avita Medical? Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Avita Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avita Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD) and Tesla (TSLA). Company Calendar Last Earnings8/07/2025Today10/07/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryMedical Equipment Current SymbolNASDAQ:RCEL CIK1762303 Webwww.avitamedical.com Phone(833) 462-8482FaxN/AEmployees130Year Founded2008Price Target and Rating Average Price Target for Avita Medical$11.60 High Price Target$21.00 Low Price Target$3.00 Potential Upside/Downside+112.8%Consensus RatingHold Rating Score (0-4)2.17 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($1.97) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$61.85 million Net Margins-68.87% Pretax Margin-68.87% Return on Equity-632.62% Return on Assets-71.52% Debt Debt-to-Equity RatioN/A Current Ratio0.58 Quick Ratio0.46 Sales & Book Value Annual Sales$74.88 million Price / Sales1.94 Cash FlowN/A Price / Cash FlowN/A Book Value$0.17 per share Price / Book32.06Miscellaneous Outstanding Shares26,619,000Free Float25,874,000Market Cap$145.07 million OptionableOptionable Beta1.64 Social Links 10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:RCEL) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avita Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avita Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.